Changes in preganglionic sympathetic nerve function following chronic morphine treatment in rats

Br J Pharmacol. 1990 Feb;99(2):247-52. doi: 10.1111/j.1476-5381.1990.tb14689.x.

Abstract

1. The effects of acute or chronic morphine treatment on the changes in blood pressure and pulse rate in response to ganglionic stimulation or blockade and to vagal stimulation, and of isolated atria to field stimulation or noradrenaline, were studied. 2. In pithed rats, intravenously injected hexamethonium significantly depressed the blood pressure responses to sympathetic nerve stimulation. The ganglionic blocking effects of hexamethonium were significantly greater in chronically morphine-treated rats, but were not significantly affected by acute morphine administration in naive animals. 3. Intravenous administration of nicotine dose-dependently increased blood pressure and pulse rate. The magnitudes of these changes were not significantly affected by acute or chronic morphine pretreatment. 4. Studies with rat isolated atrial preparations revealed that the changes in atrial contractile rate and force in response to noradrenaline or field stimulation were not influenced by either acute or chronic morphine treatment. 5. Cervical vagal stimulation produced voltage- or frequency-dependent decreases in pulse rate and blood pressure. The responses were not significantly affected by chronic morphine treatment. 6. These findings suggest that the site of the changes in sympathetic function following prolonged exposure to the opiate appears to be on the preganglionic nerve fibres.

MeSH terms

  • Animals
  • Blood Pressure / drug effects
  • Electric Stimulation
  • Female
  • Ganglionic Blockers / pharmacology
  • Heart / drug effects
  • Hemodynamics / drug effects
  • Hexamethonium Compounds / pharmacology
  • Morphine / pharmacology*
  • Neural Pathways / drug effects
  • Nicotine / pharmacology
  • Rats
  • Rats, Inbred Strains
  • Sympathetic Nervous System / drug effects*
  • Vagus Nerve / drug effects
  • Vagus Nerve / physiology

Substances

  • Ganglionic Blockers
  • Hexamethonium Compounds
  • Nicotine
  • Morphine